{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:22:37Z","timestamp":1648783357866},"reference-count":23,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.cca.2011.02.032","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T20:29:31Z","timestamp":1299529771000},"page":"1155-1160","source":"Crossref","is-referenced-by-count":0,"title":["Two unusual cases of intractable hyperthyroidism responsive to octreotide: Munchausen syndrome or not?"],"prefix":"10.1016","volume":"412","author":[{"given":"Jian-Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Qun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Yi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bang-Yao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Ju","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Yin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Mo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Long","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Zhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Yan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Lun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.02.032_bb0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ecl.2006.09.008","article-title":"Thyrotoxicosis and thyroid storm","volume":"35","author":"Nayak","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.cca.2011.02.032_bb0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/rg.234025716","article-title":"Scintigraphic manifestations of thyrotoxicosis","volume":"23","author":"Intenzo","year":"2003","journal-title":"Radiographics"},{"key":"10.1016\/j.cca.2011.02.032_bb0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2011.02.032_bb0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2008-1071002","article-title":"Preoperative treatment of intractable hyperthyroidism with acute lithium administration","volume":"6","author":"Kauschansky","year":"1996","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/j.cca.2011.02.032_bb0025","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1210\/jc.2005-0608","article-title":"Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: long-term outcome of a randomized controlled trial","volume":"90","author":"Bal","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2011.02.032_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF03018544","article-title":"Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves' disease with Iopanoic acid\u2014a case report","volume":"51","author":"Pandey","year":"2004","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.cca.2011.02.032_bb0035","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2004-1334","article-title":"Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study","volume":"90","author":"Wemeau","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2011.02.032_bb0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0026-0495(92)90033-7","article-title":"Treatment of thyroid-stimulating hormone-secreting adenomas with octreotide","volume":"41","author":"Chanson","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2011.02.032_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2011.02.032_bb0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(51)92313-6","article-title":"Munchausen's syndrome","volume":"1","author":"Asher","year":"1951","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2011.02.032_bb0055","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.resuscitation.2007.06.001","article-title":"Acute respiratory failure leading to emergency intubation: an unusual manifestation of Munchausen's syndrome","volume":"75","author":"Klaassen","year":"2007","journal-title":"Resuscitation"},{"key":"10.1016\/j.cca.2011.02.032_bb0060","first-page":"399","article-title":"Selective central activation of somatostatin receptor 2 increases food intake, grooming behavior and rectal temperature in rats","volume":"61","author":"Stengel","year":"2010","journal-title":"J Physiol Pharmacol."},{"key":"10.1016\/j.cca.2011.02.032_bb0065","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1523\/JNEUROSCI.5295-09.2010","article-title":"Somatostatin signaling in neuronal cilia is critical for object recognition memory","volume":"30","author":"Einstein","year":"2010","journal-title":"J Neurosci."},{"key":"10.1016\/j.cca.2011.02.032_bb0070","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/EJE-08-0462","article-title":"Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader\u2013Willi syndrome","volume":"159","author":"De Waele","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cca.2011.02.032_bb0075","first-page":"3191","article-title":"Treatment of hyperthyroidism with a combination of methimazole and cholestyramine","volume":"81","author":"Mercado","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2011.02.032_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12020-008-9107-5","article-title":"Low doses of cholestyramine in the treatment of hyperthyroidism","volume":"34","author":"Kaykhaei","year":"2008","journal-title":"Endocr"},{"key":"10.1016\/j.cca.2011.02.032_bb0085","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1210\/jcem.86.6.7593","article-title":"Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas","volume":"86","author":"Caron","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2011.02.032_bb0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.mce.2007.10.015","article-title":"Somatostatin and somatostatin receptors in Cushing's disease","volume":"286","author":"Hofland","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cca.2011.02.032_bb0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2265.2008.03301.x","article-title":"Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients","volume":"69","author":"Faggiano","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2011.02.032_bb0100","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1530\/eje.0.1360416","article-title":"Lanreotide in the treatment of patients with thyroid eye disease","volume":"136","author":"Krassas","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cca.2011.02.032_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/thy.1997.7.21","article-title":"Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-octreotide","volume":"7","author":"Moncayo","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.cca.2011.02.032_bb0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","article-title":"Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use","volume":"27","author":"Reubi","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.cca.2011.02.032_bb0115","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2007.12.7431","article-title":"Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors","volume":"26","author":"Asnacios","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111001239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111001239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T06:51:08Z","timestamp":1543906268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898111001239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":23,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0009898111001239"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.02.032","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}